 |
|
Angiotensin converting enzyme inhibitors remain the first treatment of choice
Pyung Chun Oh, Ichiro Sakuma, Toshio Hayashi, Kwang Kon Koh
Korean J Intern Med. 2016;31(2):237-241. Published online 2016 Feb 26 DOI: https://doi.org/10.3904/kjim.2016.026
|
|
Citations to this article as recorded by
 Use of kefir peptide (Kef-1) as an emerging approach for the treatment of oxidative stress and inflammation in 2K1C mice
Rafaela Aires, Fernanda Gobbi Amorim, Larissa Zambom Côco, Amanda Pompermayer da Conceição, Tadeu Ériton Caliman Zanardo, Gabriel Henrique Taufner, Breno Valentim Nogueira, Elisardo Corral Vasquez, Thiago Melo Costa Pereira, Bianca Prandi Campagnaro, Silv
Food & Function.2022; 13(4): 1965. CrossRef Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease
Kyoung Im Cho, Ichiro Sakuma, Il Suk Sohn, Sang-Ho Jo, Kwang Kon Koh
Atherosclerosis.2018; 277: 60. CrossRef Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
Kwang Kon Koh, Ichiro Sakuma, Kazunori Shimada, Toshio Hayashi, Michael J. Quon
Korean Circulation Journal.2017; 47(4): 432. CrossRef
|